Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : OTC Shell Search and DD... -- Ignore unavailable to you. Want to Upgrade?

To: Esa who wrote (848)	5/5/2001 8:55:09 AM
From: Esa	Read Replies (1) \| Respond to of 858

PERS Personal Diagnostics, Incorporated is pursuing various business alternatives including possible acquisition of an existing business. Prior to May 15, 1995, the Company operated a contract manufacturing business primarily devoted to the production of orthopedic products and the assembly of various medical systems. During early fiscal 1995, the Company essentially completed its assembly operations and in May 1995, concluded the sale of its manufacturing plant and equipment to EBI Medical Systems, Inc. Since 1995, the Company has considered various business alternatives including the possible acquisition of an existing business, but to date has found possible opportunities unsuitable or excessively priced.

To: Esa who wrote (848)	5/6/2001 6:24:05 PM
From: Glenn Petersen	Respond to of 858

It looks like ABIO is going to liquidate the company. From the recently filed Form 10-K: freeedgar.com "The Company ceased its ongoing business operations in August of 2000 because the Company determined it would be unable to complete the development of its primary product, the Basis System, for market and sale. The Company's Chief Executive Officer resigned and all other employees were terminated. The Company has wound down its business operations, eliminated expenses and negotiated the termination or satisfaction of all of its remaining obligations. Currently, the Company's management and accounting functions are performed through Manchester. "The Company adopted liquidation basis accounting as of September 1, 2000. This basis of accounting is considered appropriate when liquidation of a company appears imminent and the net realizable value of its assets are reasonably determinable. Under this basis of accounting, assets and liabilities are stated at their net realizable value and estimated costs through the liquidation date are provided to the extent reasonably determinable." As of December 31, 2000, the company had 5,883,404 shares outstanding and net assets, calculated in conformity with liquidation based accounting, or $732,527. That works out to approximately $.125 per share.